According to COSMIC data, FBXW7 mutations occur in approximately 7.8% of all human cancers, with the highest prevalence in cholangiocarcinoma (35%), T-cell acute lymphoblastic leukemia (31%), endometrial (9%), and gastric cancers (6%). Here, FBXW7 is linked to cancer.